Available every Friday morning, The Top Line podcast will recap the biggest news and why it matters—from mergers and marketing to drug R&D and device development.
In this episode of “The Top Line,” we explore the growing space of biopharma prediction markets, how they work and the risks they create around insider information and clinical trial integrity.
